Target intelligence / Profile preview

Yersinia pestis F1-V Fusion Antigen (F1-V)

Target
F1-V
Molecular classification
Recombinant protein, Fusion protein, Antigen
01

Overview

The F1-V fusion antigen is a recombinant protein combining the F1 capsular antigen and the V antigen of Yersinia pestis. It is designed to induce a strong and broad immune response, including both humoral and cell-mediated immunity, against plague. It engages TLR2 signaling and elicits T-cell responses, leading to protective immunity against both bubonic and pneumonic forms of the disease. It is a promising target for next-generation anti-plague vaccines.

Other names
F1-V fusion proteinF1V antigenrF1-V
02

Mechanism of action

The F1-V fusion antigen stimulates the immune system to produce antibodies and activate T-cells that target Yersinia pestis, leading to protection against plague.

03

Biological functions

Immune response inductionAntigen presentationTLR2 signalingAntibody productionT-cell activation
04

Disease associations

Plague (Yersinia pestis infection)Infectious diseaseBacterial infection
05

Safety considerations

Potential for allergic reactionsAdverse reactions to vaccine excipientsImmunogenicity in immunocompromised individuals needs careful evaluation
06

Biomarkers

Anti-F1-V IgG antibody titersIFNγ production by splenocytesIL-17 production by splenocytes

Beyond the preview

Go deeper on Yersinia pestis F1-V Fusion Antigen (F1-V).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yersinia pestis F1-V Fusion Antigen (F1-V).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call